Effects of Smoking Cessation on Illicit Drug Use among Opioid Maintenance Patients: A Pilot Study.
Opioid treatment program patients and staff often have concerns that smoking cessation may jeopardize abstinence from illicit drug use. In this study, we evaluated whether smoking abstinence produced with a two-week contingency-management (CM) intervention was associated with relapse to illicit drug use among patients enrolled in opioid maintenance. Opioid-maintenance patients who were stable in treatment and abstinent from illicit drugs were enrolled in a 14-day smoking-cessation study. Participants were dichotomized into Abstainers (> 90% smoking-negative samples, n=12) and Smokers (< 10% smoking-negative samples, n=16). Illicit drug assays included opioids, oxycodone, propoxyphene, cannabis, amphetamines, cocaine and benzodiazepines. There were no differences between the Abstainers and Smokers, with 99% and 96% of samples testing negative for all illicit drugs in each group, respectively. Data from this study provide no evidence that smoking cessation among stable opioid-maintained patients undermines drug abstinence and lend support for programs that encourage smoking cessation during drug abuse treatment.
Dunn
Kelly E
KE
Department of Psychology, University of Vermont.
Sigmon
Stacey C
SC
Reimann
Edward
E
Heil
Sarah H
SH
Higgins
Stephen T
ST
MMWR Morb Mortal Wkly Rep. 2005 Jul 1;54(25):625-8
15988406
J Addict Dis. 1993;12(4):89-104
8292642
BMJ. 1994 Oct 1;309(6958):842-6
7950614
Addict Behav. 2002 Nov-Dec;27(6):887-910
12369474
Int J Addict. 1991 Jan;26(1):91-106
2066174
J Consult Clin Psychol. 2004 Dec;72(6):1144-56
15612860
Nicotine Tob Res. 2005 Jun;7(3):475-80
16085516
Nicotine Tob Res. 2002;4 Suppl 2:S175-82
12573178
J Pharmacol Exp Ther. 1984 Jun;229(3):636-40
6726650
Am J Addict. 2001 Spring;10(2):159-66
11444157
Addict Behav. 1987;12(3):209-15
3661273
J Nerv Ment Dis. 1985 Jul;173(7):412-23
4009158
Drug Alcohol Depend. 2006 Nov 8;85(2):138-41
16720082
J Subst Abuse Treat. 1993 Mar-Apr;10(2):189-95
8510193
JAMA. 1996 Apr 10;275(14):1097-103
8601929
Addict Behav. 1983;8(4):403-12
6677081
Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S59-77
12738351
Psychopharmacology (Berl). 1985;86(4):417-25
3929312
Exp Clin Psychopharmacol. 1997 Aug;5(3):263-8
9260074
J Subst Abuse Treat. 1995 Jul-Aug;12(4):247-52
8830151
JAMA. 1994 Feb 23;271(8):589-94
8301790
Addiction. 2002 Oct;97(10):1317-28; discussion 1325
12359036
J Addict Dis. 2005;24(2):33-48
15784522
Prev Med. 1994 Jan;23(1):61-9
8016035
Br J Gen Pract. 1996 Mar;46(404):145-8
8731618
Br J Addict. 1991 Sep;86(9):1119-27
1932883
J Appl Behav Anal. 2008 Winter;41(4):527-38
19192857
Psychiatr Serv. 1995 Sep;46(9):945-7
7583510
Addict Behav. 1989;14(3):273-8
2750568
Drug Alcohol Depend. 1997 Mar 14;44(2-3):123-32
9088784
J Subst Abuse Treat. 2008 Jul;35(1):68-77
17951021
Nicotine Tob Res. 2004 Dec;6(6):1015-20
15801574
J Addict Dis. 1998;17(2):9-19
9567223
Alcohol Clin Exp Res. 1994 Aug;18(4):867-72
7978097
Nicotine Tob Res. 2002 May;4(2):149-59
12028847
Am J Public Health. 2001 Feb;91(2):296-9
11211643
Am J Addict. 2005 Jul-Sep;14(4):358-66
16188716
Addict Behav. 2006 Nov;31(11):2127-34
16473476
J Subst Abuse Treat. 2007 Jan;32(1):53-60
17175398
Fed Regist. 2001 Jan 17;66(11):4076-102
11503765
J Psychoactive Drugs. 2006 Sep;38(3):311-5
17165374
Drug Alcohol Depend. 2000 Feb 1;58(1-2):103-9
10669060
J Subst Abuse Treat. 1995 Mar-Apr;12(2):89-94
7623395